TISA-818-Inj

DRUG2 trials

Sponsors

EnliTISA (Shanghai) Pharmaceutical Co., Ltd.

Conditions

Acute Respiratory Distress Syndrome (ARDS)Healthy Subjects

Phase 1

Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Subjects After Subcutaneous Injection of TISA-818-Inj

CompletedNCT07337044

EnliTISA (Shanghai) Pharmaceutical Co., Ltd.Healthy Subjects

Start: 2024-01-24End: 2024-10-16Updated: 2026-01-13

Phase 2

Safety and Preliminary Efficacy of TISA-818 Injection in Patients With Acute Respiratory Distress Syndrome

CompletedNCT07319351

EnliTISA (Shanghai) Pharmaceutical Co., Ltd.Acute Respiratory Distress Syndrome (ARDS)

Start: 2023-10-12End: 2025-09-15Updated: 2026-01-06